October 26, 2021

Volume XI, Number 299

Advertisement
Advertisement

October 25, 2021

Subscribe to Latest Legal News and Analysis

Intellectual Property, Patent, Trademark and Copyright Law News

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

For hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Date Title Organization
24
Oct
Dulles CBP Officers Seize more than $1 Million in Counterfeit Consumer Goods U.S. Customs and Border Protection
23
Oct
Trade Secret Implications of Facebook’s Frances Haugen’s Testimony: Do NDAs Protect Trade Secrets Against Whistleblowers? The National Law Review / The National Law Forum LLC
23
Oct
China’s Shanghai Pudong Court Sentences 69 Defendants for Counterfeiting Chanel, Cartier and Gucci Products for up to 5 Years 9 Months with a $1.8 Million USD Fine Schwegman, Lundberg & Woessner, P.A.
22
Oct
Easy to Start, Potentially Hard to Finish: Considerations for Retailers in Appealing an IPR Decision Hunton Andrews Kurth
21
Oct
China’s Supreme People’s Court Submits Report to the National People’s Congress on Judicial Work on the People’s Courts in Intellectual Property Schwegman, Lundberg & Woessner, P.A.
21
Oct
EXCLUSIVE RIGHTS: Intellectual Property — Don’t Get Caught Double Patenting! [PODCAST] Mintz
21
Oct
Means-Plus-Function Claims: Don’t Forget the “Way” McDermott Will & Emery
21
Oct
NDA Forum Selection Clause Doesn’t Bar IPR in Response to Subsequent Infringement Suit McDermott Will & Emery
21
Oct
PTO’s Financial Benefits from IPR Don’t Render PTAB Unconstitutional McDermott Will & Emery
21
Oct
Update: Absent Explicit Statutory Language? The American Rule Still Applies McDermott Will & Emery
21
Oct
USPTO Sanctions U.S. Patent Attorney for Renting out Bar Registration to Chinese Trademark Agency to File Trademark Applications Schwegman, Lundberg & Woessner, P.A.
20
Oct
Prosecution Pointers 295-299 Finnegan
19
Oct
Protecting Image and Likeness Through Trademark Law Stubbs Alderton & Markiles, LLP
19
Oct
During a Global Health Crisis, IP Rights Are Getting a Bad Rap Polsinelli PC
16
Oct
CareDx v. Natera – Are Processing Steps Known to the Art Always “Conventional”? Schwegman, Lundberg & Woessner, P.A.
15
Oct
Trade Secret Misappropriation: Denial of Motion for Attorneys’ Fees under CUTSA is Not an Appealable Order Sheppard, Mullin, Richter & Hampton LLP
15
Oct
AFCP 2.0 Extended: Your Mileage May Vary Squire Patton Boggs (US) LLP
14
Oct
China’s National Intellectual Property Administration to Cease Issuing Paper Trademark Certificates Schwegman, Lundberg & Woessner, P.A.
14
Oct
Authentication Claim Under Alice—A Two-Step Process McDermott Will & Emery
14
Oct
Oh the Horror: No Work for Hire in Friday the 13th Screenplay McDermott Will & Emery

Pages

Advertisement
Advertisement